MedTrace Logo

Serum LncRNAs as Early Potential Biomarkers for the Prediction of Preeclampsia

NCT03903393 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2019-12-17

No results posted yet for this study

Summary

To identify lncRNAs differentially expressed at early stages of gestation in the serum of pregnant women, who later developed severe preeclampsia (sPE) in the third trimester of pregnancy compared to women with normal pregnancy .

Conditions

Sponsors & Collaborators

  • First Affiliated Hospital of Harbin Medical University

    lead OTHER

Principal Investigators

  • Yue Li · First Affiliated Hospital of Harbin Medical University

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-31
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03903393 on ClinicalTrials.gov